Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) hit a new 52-week high during trading on Monday . The company traded as high as $248.15 and last traded at $246.9920, with a volume of 530704 shares changing hands. The stock had previously closed at $246.96.
First Trust NYSE Arca Biotechnology Index Fund Price Performance
The firm has a market cap of $2.80 billion, a P/E ratio of 21.72 and a beta of 0.68. The firm’s 50 day moving average is $218.52 and its 200 day moving average is $211.21.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in FBT. First Trust Advisors LP grew its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 49,660.7% in the first quarter. First Trust Advisors LP now owns 3,515,093 shares of the company’s stock worth $705,900,000 after acquiring an additional 3,508,029 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 4,370.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 577,231 shares of the company’s stock worth $119,210,000 after purchasing an additional 564,319 shares during the last quarter. Morgan Stanley raised its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 18.2% in the 4th quarter. Morgan Stanley now owns 401,201 shares of the company’s stock worth $82,856,000 after purchasing an additional 61,755 shares during the last quarter. LPL Financial LLC boosted its stake in First Trust NYSE Arca Biotechnology Index Fund by 30.0% in the 4th quarter. LPL Financial LLC now owns 260,833 shares of the company’s stock worth $53,867,000 after purchasing an additional 60,187 shares in the last quarter. Finally, Bank of America Corp DE boosted its stake in First Trust NYSE Arca Biotechnology Index Fund by 5.7% in the 1st quarter. Bank of America Corp DE now owns 200,959 shares of the company’s stock worth $40,357,000 after purchasing an additional 10,853 shares in the last quarter.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
See Also
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
